← Eichor
Condition: Hematopoietic Cell Transplantation Hct Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hematopoietic Cell Transplantation Hct

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Phase 1/Phase 2 · 4 location(s) · Arkansas Children's Hospital Research Institute · NCT07252050Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Re
Phase 1/Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT07225985Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Phase 2 · 3 location(s) · Children's Hospital of Philadelphia · NCT05194397MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Se
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT06412497Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyc
Phase 1 · 2 location(s) · University of Kansas Medical Center · NCT03533816Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03579875HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Ste
Phase 1 · 1 location(s) · Fred Hutchinson Cancer Center · NCT03326921Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
Phase 2 · 1 location(s) · St. Petersburg State Pavlov Medical University · NCT06532084A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transpl
Phase 3 · 26 location(s) · TScan Therapeutics, Inc. · NCT07702578Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction i
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT05664113A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an
Phase 2 · 6 location(s) · Memorial Sloan Kettering Cancer Center · NCT05736419Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hem
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT07046078TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
Phase 2 · 1 location(s) · Johns Hopkins All Children's Hospital · NCT04356469Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_Phase 1 · 2 location(s) · Sumithira Vasu · NCT03665675Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
Phase 3 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06381817Ivosidenib as Post-HSCT Maintenance for AML
Phase 2 · 6 location(s) · Massachusetts General Hospital · NCT06707493Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
Phase 2 · 5 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07304232Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
Phase N/A · 16 location(s) · Peking University People's Hospital · NCT07349498Defibrotide Dose-escalation for SOS Post-HSCT
Phase 2 · 1 location(s) · New York Medical College · NCT05987124Ziftomenib Maintenance Post Allo-HCT
Phase 1 · 2 location(s) · Massachusetts General Hospital · NCT06440135Haploidentical HCT for Severe Aplastic Anemia
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT04558736Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoieti
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT07052630Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therap
Phase N/A · 37 location(s) · University of Rochester · NCT06941389Virtual Rehabilitation in HCT
NA · 1 location(s) · Emory University · NCT05943964A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Phase 3 · 81 location(s) · SymBio Pharmaceuticals · NCT07387367BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
Phase 2 · 1 location(s) · St. Petersburg State Pavlov Medical University · NCT06477549Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · 35 location(s) · University Hospital Freiburg · NCT06830421Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03000244Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation
Phase 2 · 2 location(s) · City of Hope Medical Center · NCT03728335HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
EARLY_Phase 1 · 1 location(s) · Duke University · NCT06731504
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.